Reliant AI | Everything you Need to Know

Mission and Vision

Founded in 2023 with a diverse team of AI enthusiasts–builders, scientists, and entrepreneurs, Reliant AI, at its core, is driven by a mission to leverage the power of AI to drastically improve the ability of organizations to excel at their work. Bringing together their expertise in reinforcement learning and natural language processes, they aim to target the challenges that plague the Pharma and Life Sciences industry and come up with sustainable and impeccable AI solutions for them.

The founding team-Luminaries in the AI industry

Reliant AI is the brainchild of some of the brightest minds in the AI industry, team leaders at tech giants like Google, DeepMind, and EY Parthenon. The founding members are as follows-

Karl Moritz Hermann- CEO

Marc Bellemare- Chief Scientific Officer

Richard Schlegel- Head of Commercial

Before we learn about the spectacular solutions that Reliant AI brings to the table, let us briefly look at some of the challenges that Research and Development companies in BioPharma and Life Sciences face when it comes to data management-

Reliant AI  | Locations

With its headquarters in Berlin, Reliant AI now has an office in Montreal as well. Check out their locations-

• Berlin Office- Mindspace c/o Reliant AI Friedrichstraße 68 10117 Berlin Germany

• Montreal Office- Montreal Cowork c/o Reliant AI 4388 Saint-Denis #200, Montréal, QC H2J 2L1

Data Management in R&D(Biopharma)- Major Challenges

1. Data Silos: A data silo is used to describe a situation when a specific set of data is isolated within the database or segregated in a manner that may make it inaccessible or not easily shareable with others, sometimes in the same organization. Data silos can arise due to the mismanagement of multiple data sources, which is ever-present in the industry. Data Silos can be highly obstructive in research as each dataset can contain years of research, valuable insights, and investments which if lost or isolated can hamper cross-referencing, patterns, etc.,

2. Data Security: The Pharmaceutical industry often deals with very sensitive data, containing confidential medical records, new research findings, etc., This makes a strong protective mechanism that can prevent data breaches, unauthorized access, and misuse. However, in the handling of such complicated data sets and lack of proper structure or organizations, the level of security may not comply with the standards demanded, which can not only have severe legal and financial repercussions for organizations but also damage their reputation and the value of their research among investors, patients and the market in general.

3. Data quality and authenticity : The Datasets collected and processed in the Pharma R&D industry may have come from multiple sources. This makes it extremely important to maintain the quality and reliability of data as it may be used for scientific analysis and research that demands the highest level of accuracy, consistency, and reliability. Even minor discrepancies can have disastrous consequences or alter results for years of research studies and theses, thus, maintaining the quality of the datasets while also making sure that it is easily reproducible and unaltered is a very important requirement when it comes to data management in the Pharma Industry.

Now that we have taken a brief look at the major challenges plaguing data management in the Pharma industry, let us learn about how the solutions offered by Reliant AI are meeting all the criteria and tackling these issues.

Transforming the BioPharma industry – Reliant Tabular

The complex and scattered research data that often hinders efficiency in most BioPharma companies is what Reliant AI is committed to change. They have come up with an uncompromising generative AI-based technology to bring accuracy, speed, and confidence to commercial biopharma.

Reliant Tabular, their cutting-edge generative AI solution driven by an advanced machine learning model is proven to revolutionize the way data is processed, scanned, and stored in the leading BioPharma companies. Built to minimize the drudgery of labor-intensive processing, organization, and inspection of the complex variety of data that such companies deal with, it assures speed, accuracy, and security, all at once.

Features of Reliant Tabular

• Speed : The proprietary Large Language Models(LLMs) employed by Reliant AI  are experts in Biopharma and are known to produce answers within seconds, not hours! Their top-notch tech allows researchers to scan assets 4.8x faster when compared to scans by hand.

• A Specialist in Fact-Finding : Leaving no nook of the database unchecked, their database-scanning algorithm can scourge data and reproduce it whenever required with a 10x less likely chance for an error when compared to an average analyst or a general-purpose AI software

• All Data in a single place : You can forget about your worries about Data silos with Reliant Tabular making sure that all of it is stored in a single place. Additionally, they also have a resource base where they index over 38 million scientific publications, conference abstracts, and clinical trials, accessible anytime.

• Data Privacy : Prioritizing data security and privacy like no other, their algorithm learns and generates information by checking open-access publications and not the database of any particular organization.

With such spectacular features, Reliant Tabular has completely transformed operations and data management for some of the leading global science companies like Hayden, Clear View, OMass Therapeutics, Kyowa Kirin, etc.,

The curious blend of cutting-edge AI research and domain expertise that Reliant AI has brought out makes it possible for a day’s worth of data processing to be completed in merely 30 seconds! One can only imagine what difference to the efficiency and research output this could bring.

You can check out their use case studies and client reviews of Reliant Tabular on their website-

https://www.reliant.ai/

Reliant AI with its innovative solutions and commendable results has attracted the attention of many venture capitalists in the software and technology market and has secured a seed funding of $11.3 M in its latest round!

The latest round of funding for Reliant AI(Aug 2024) – $11.3 M in Seed Funding

The funding was co-led by Tola Capital and Inovia Capital with participation from angel investor Mike Volpi.

With the immense interest and recognition that Reliant Tabular has attracted among key business segments in the Biopharma industry, and the promising potential that this startup, with a technical team bringing together decades of experience and expertise, investors across various firms consider it a worthwhile market opportunity.

“We see a significant market opportunity in the pharmaceutical sector, as companies strive to build and partner with new entrants to develop innovative solutions like those offered by Reliant AI,” 

– Steve Woods, Partner at Inovia Capital.